Evaluation of an Immersive Audiovisual Distraction Device Impact on Peroperative Opioid Consumption. A Prospective Randomized Controlled Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Surgical Procedure, Unspecified
- Sponsor
- University Hospital, Caen
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Intraoperative Remifentanil dose
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption for outpatient procedures with Remifentanil added to local anesthesia.
Half of patients will receive an audiovisual distraction device while the other half not.
Detailed Description
Early recovery for patients undergoing surgery is the key factor for an outpatient procedure. The technique of adding remifentanil to a local anesthesia is used in 22% of the procedures realized in The CHU de Caen Outpatient unit. Decreasing opioid dose, whose side effects are numerous and widely described, as well as reducing anxiety are daily challenges to ensure comfort and successful care. We propose a prospective, randomized, monocentric, open label study to evaluate the impact of the use of an audiovisual distraction device on the intraoperative consumption of opioids, on the patient's pain and peroperative anxiety. ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement. We will analyze if audiovisual distraction can integrate existing techniques such as hypnosis. Finally, we will also assess the medico-economic impact of this technique in order to establish a benefit / cost ratio.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patient
- •Signed consent
- •Outpatient surgery eligibility
- •Patient covered by social security
Exclusion Criteria
- •Unsigned consent
- •Study participation refusal
- •Deafness, blindness
- •Claustrophobia
- •ANI contraindication (atrial fibrillation, pace maker, severe autonomic system dysfunction)
- •Contraindication or impossibility to use the audiovisual distraction device
Outcomes
Primary Outcomes
Intraoperative Remifentanil dose
Time Frame: 1 hour
μg/kg/min
Secondary Outcomes
- Preoperative pain measured with a numeric pain rating scale (NRS)(1 hour)
- Post operative anxiety measured by a visual analogue scale (VAS)(1 hour)
- Preoperative anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS)(1 hour)
- Preoperative anxiety measured by a visual analogue scale (VAS)(1 hour)
- Per operative Analgesia nociception index (ANI) value(1 hour)
- Postoperative pain measured with a numeric pain rating scale (NRS)(1 hour)